We found that females with MS had decreased SIRT1 serum levels compared to control group females (0.090 (0.047) ng/mL vs. 1.963 (2.614) ng/mL, p < 0.001) (Figure 2). This evidence concerns the gene SIRT1 and myeloid sarcoma.